Essity Faces Investors' Claim Over Chinese Tissue Biz Sale
A group of investment companies has sued Essity at a London court, alleging that the manufacturer of hygiene and health products defaulted on bond notes when it sold its controlling stake in a...To view the full article, register now.
Already a subscriber? Click here to view full article